• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立人类致癌物关键特征数据库。

Development of a database on key characteristics of human carcinogens.

机构信息

McLaughlin Centre for Population Health Risk Assessment, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Department of Community and Environmental Health, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

出版信息

J Toxicol Environ Health B Crit Rev. 2019;22(7-8):264-287. doi: 10.1080/10937404.2019.1642593. Epub 2019 Aug 4.

DOI:10.1080/10937404.2019.1642593
PMID:31379270
Abstract

A database on mechanistic characteristics of human carcinogenic agents was developed by collecting mechanistic information on agents identified as human carcinogens (Group 1) by the International Agency for Research on Cancer (IARC) in the . A two-phase process is described for the construction of the database according to 24 toxicological endpoints, derived from appropriate test systems that were acquired from data obtained from the mechanisms sections of the IARC Monographs (Section 4) and a supplementary PubMed search. These endpoints were then aligned with 10 key characteristics of human carcinogens that reflect the broader attributes of these agents relating to the development of cancer in humans. The considerations involved in linking of toxicological endpoints to key characteristics are described and specific examples of the determination of key characteristics for six specific agents (tamoxifen, hepatitis B virus, arsenic, ultraviolet and solar radiation, tobacco smoking, and dioxin) are provided. Data for humans and animals were tabulated separately, as were results for and for sources of information. The database was constructed to support a separate analysis of the expression of these endpoints by 86 Group 1 carcinogens, and along with an analysis of the key characteristics of these agents.

摘要

建立了一个人类致癌剂机制特征数据库,通过收集国际癌症研究机构(IARC)确定的人类致癌物(第 1 组)的机制信息来完成。根据从 IARC 专论(第 4 节)的机制部分和补充的 PubMed 搜索中获得的数据,描述了一个适用于 24 个毒理学终点的数据库构建的两阶段过程,这些终点源自适当的测试系统。这些终点随后与反映这些与人类癌症发生相关的更广泛属性的人类致癌物的 10 个关键特征相匹配。描述了将毒理学终点与关键特征联系起来的考虑因素,并提供了六个特定物质(三苯氧胺、乙型肝炎病毒、砷、紫外线和太阳辐射、吸烟和二恶英)确定关键特征的具体示例。数据按人类和动物分别列出,按 和 信息来源列出结果。该数据库的构建旨在支持对 86 种第 1 组致癌物、 以及这些物质的关键特征的这些终点的单独分析。

相似文献

1
Development of a database on key characteristics of human carcinogens.建立人类致癌物关键特征数据库。
J Toxicol Environ Health B Crit Rev. 2019;22(7-8):264-287. doi: 10.1080/10937404.2019.1642593. Epub 2019 Aug 4.
2
Key characteristics of 86 agents known to cause cancer in humans.已知 86 种人类致癌剂的关键特征。
J Toxicol Environ Health B Crit Rev. 2019;22(7-8):244-263. doi: 10.1080/10937404.2019.1643536. Epub 2019 Oct 22.
3
Overview of biological mechanisms of human carcinogens.人类致癌物的生物学机制概述。
J Toxicol Environ Health B Crit Rev. 2019;22(7-8):288-359. doi: 10.1080/10937404.2019.1643539. Epub 2019 Oct 20.
4
IARC Workshop on the Key Characteristics of Carcinogens: Assessment of End Points for Evaluating Mechanistic Evidence of Carcinogenic Hazards.国际癌症研究机构致癌物关键特性研讨会:评估用于评价致癌危害机制证据的终点指标
Environ Health Perspect. 2025 Feb;133(2):25001. doi: 10.1289/EHP15389. Epub 2025 Feb 3.
5
Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans.人类肿瘤发生部位与 111 种人类致癌剂在实验动物中的肿瘤发生部位的一致性。
J Toxicol Environ Health B Crit Rev. 2019;22(7-8):203-236. doi: 10.1080/10937404.2019.1642586.
6
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis.致癌物的关键特征作为整理致癌机制数据的基础。
Environ Health Perspect. 2016 Jun;124(6):713-21. doi: 10.1289/ehp.1509912. Epub 2015 Nov 24.
7
Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC Monographs on the identification of carcinogenic hazards to humans: Patterns and associations.IARC 专著中利用人类致癌物关键特征对机制证据进行组织和评估以识别人类致癌危害的十年:模式和关联。
Toxicol Sci. 2024 Feb 28;198(1):141-154. doi: 10.1093/toxsci/kfad134.
8
Development of a database on tumors and tumor sites in humans and in experimental animals for 'Group 1 agents identified through volume 109 of the .为通过第 109 卷确定的“第 1 组物质”建立一个关于人类和实验动物肿瘤及肿瘤部位的数据库。
J Toxicol Environ Health B Crit Rev. 2019;22(7-8):237-243. doi: 10.1080/10937404.2019.1642601. Epub 2019 Oct 15.
9
The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.对多种小鼠器官进行彗星试验:将彗星试验结果与从国际癌症研究机构专论和美国国家毒理学计划致癌性数据库中选取的208种化学物质的致癌性进行比较。
Crit Rev Toxicol. 2000 Nov;30(6):629-799. doi: 10.1080/10408440008951123.
10
Genetic toxicology data in the evaluation of potential human environmental carcinogens.潜在人类环境致癌物评估中的遗传毒理学数据。
Mutat Res. 1999 Jul;437(1):21-49. doi: 10.1016/s1383-5742(99)00037-x.

引用本文的文献

1
Genotoxicity Induced by Carcinogenic Agents or Occupational Exposure with Sufficient Evidence for Bladder Cancer.致癌剂或职业暴露诱导的遗传毒性,有充分证据证明与膀胱癌有关。
J Clin Med. 2025 Jun 25;14(13):4492. doi: 10.3390/jcm14134492.
2
Epigenetic Changes Induced by Carcinogenic Agents or Occupational Exposure with Sufficient Evidence for Bladder Cancer.致癌剂或职业暴露诱导的表观遗传变化与膀胱癌有充分证据。
Cancer Prev Res (Phila). 2025 Aug 1;18(8):439-451. doi: 10.1158/1940-6207.CAPR-24-0450.
3
ICH S1 prospective evaluation study: weight of evidence approach to predict outcome and value of 2-year rat carcinogenicity studies. A report from the regulatory authorities subgroup.
国际人用药品注册技术协调会S1前瞻性评估研究:采用证据权重法预测两年期大鼠致癌性研究的结果及价值。监管当局小组的报告
Front Toxicol. 2024 Apr 11;6:1353783. doi: 10.3389/ftox.2024.1353783. eCollection 2024.
4
Ten years of using key characteristics of human carcinogens to organize and evaluate mechanistic evidence in IARC Monographs on the identification of carcinogenic hazards to humans: Patterns and associations.IARC 专著中利用人类致癌物关键特征对机制证据进行组织和评估以识别人类致癌危害的十年:模式和关联。
Toxicol Sci. 2024 Feb 28;198(1):141-154. doi: 10.1093/toxsci/kfad134.
5
Issue analysis: key characteristics approach for identifying endocrine disruptors.问题分析:识别内分泌干扰物的关键特征方法。
Arch Toxicol. 2023 Oct;97(10):2819-2822. doi: 10.1007/s00204-023-03568-3. Epub 2023 Aug 12.
6
Effects of soybean isoflavone aglycone on osteoporosis in ovariectomized rats.大豆异黄酮苷元对去卵巢大鼠骨质疏松症的影响。
Front Nutr. 2023 Jun 5;10:1122045. doi: 10.3389/fnut.2023.1122045. eCollection 2023.
7
Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001-2018: a national population-based cohort study.2001-2018 年台湾禁用含马兜铃酸中草药制剂后尿路上皮癌发病率的趋势:一项基于全国人群的队列研究。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8201-8211. doi: 10.1007/s00432-023-04771-6. Epub 2023 Apr 15.
8
Approaches In Carcinogenicity Hazard Assessment: Current Status and Future Needs.致癌性危害评估方法:现状与未来需求
Comput Toxicol. 2021 Nov;20. doi: 10.1016/j.comtox.2021.100191. Epub 2021 Sep 23.
9
Assessment of Mechanistic Data for Hexavalent Chromium-Induced Rodent Intestinal Cancer Using the Key Characteristics of Carcinogens.基于致癌物关键特征评估六价铬诱导啮齿类动物肠道肿瘤的机制数据
Toxicol Sci. 2021 Feb 26;180(1):38-50. doi: 10.1093/toxsci/kfaa187.